Sentences with phrase «developing cell replacement»
Recognizing there is still a tremendous need for better diabetes treatments, ViaCyte remains dedicated to developing cell replacement technologies as a way to significantly improve patients» lives.»
http://viacyte.com/ Not exact matches
ReInnervate, a start - up in Durham, England, is developing a tiny, three - dimensional plastic scaffolding on which human cells can be grown into artificial tissue, and perhaps eventually into replacements for organs.
The embryonic cells can develop into replacement organs in the lab or be injected into an egg, where they develop as a viable embryo and are literally born.
Researchers at the University of Minnesota have developed a new, carbon - neutral way to convert vegetable - based fuels to syngas, a breakthrough that could allow producers to power hydrogen fuel cells or create a replacement for America's dwindling supplies of natural gas, all without relying on fossil fuels.
For example, one of the goals of stem cell research is to develop methods for the replacement of damaged tissues in the future.
In addition, the sources of the replacement nuclei were the egg donors» own cumulus cells, which encircle developing eggs in the ovary.
Before scientists and engineers can realize the dream of using stem cells to create replacements for worn out organs and battle damaged body parts, they'll have to develop ways to grow complex three - dimensional structures in large volumes and at costs that won't bankrupt health care systems.
The findings are a major step towards developing a stem cell replacement therapy for muscle diseases including Duchenne Muscular Dystrophy, which affects approximately 1 in 5,000 boys in the U.S. and is the most common fatal childhood genetic disease.
«Our long term goal is to develop a personalized cell replacement therapy using a patient's own cells to treat boys with Duchenne,» said Hicks.
The cells generated in the Zeng lab may not only provide a potential unlimited source for cell replacement therapy for Parkinson's disease, but also offer an unprecedented opportunity to develop screening models for assessing small molecule drugs and to clarify the mechanisms of disease.
The new stem cell, developed at the Salk Institute, holds promise for one day growing replacement functional cells and tissues.
The new stem cell (green), developed at the Salk Institute, holds promise for one day growing replacement functional cells and tissues.
A St. Louis orthopedic researcher has developed a way to grow a hip replacement out of stem cells found in a patient's fat reserves, and is now testing it in animals.
«These events offer several venues and platforms to share the exciting progress ViaCyte is making in developing novel cell replacement therapies for diabetes,» said Paul Laikind, PhD, President and CEO of ViaCyte.
(required) Advanced Cell Culture: 3D, Fluid Flow and Co-cultureIn Vitro Models for the Study of Neurological DiseasesStem Cells: Developing Off the Shelf TherapeuticsCreating More Realistic Gut ModelsIn Vitro Models for Animal Replacement
In addition, the funding will be used to support other operations including the continued development of the PEC - Encap ™ product candidate, ViaCyte's stem cell - derived islet replacement therapy that is being developed as a treatment for all diabetes patients who require insulin to control their disease.
San Diego, California, October 6, 2014 — ViaCyte, Inc., a privately - held regenerative medicine company developing a stem cell - derived islet replacement therapy for the treatment of diabetes, called VC - 01 ™, will give two presentations at the annual Stem Cell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological Studies, as follcell - derived islet replacement therapy for the treatment of diabetes, called VC - 01 ™, will give two presentations at the annual Stem Cell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological Studies, as follCell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological Studies, as follows:
The WFIRM research team is working to engineer replacement tissues and organs and develop healing cell therapies for more than 30 different areas of the body.
The Society believes that research involving the transfer of a human nucleus into an animal egg will lead to important new knowledge about cell nuclear replacement (CNR) technology and, if it were to prove possible to produce embryonic stem cells by this route, would increase understanding of how to programme these cells to develop into different tissue types.
«Dr. Ding's latest research offers new hope for the process of developing medications for these diseases, as well as for the possibility of cell - replacement therapy to reduce the trauma of millions of people affected by these devastating and irreversible conditions.»
Diabetes Forecast highlighted ViaCyte's first - of - a-kind islet cell replacement therapy in an article discussing twelve innovative products being developed to treat and manage type 1 diabetes.
As the first company to advance a cell replacement therapy for type 1 diabetes into the clinic, ViaCyte is committed to developing a functional cure for all type 1 diabetes patients.
Given our extensive experiences in neuronal differentiation of hESCs [6], [7], [8] and the potential application of hESC - derived neurons in cell replacement therapies for neurodegenerative diseases, we designed a set of experiments aimed at developing a hESC - based automated assay for screening small molecules that have differential toxicity to hESC - derived NSCs and their differentiated neural progenies.
Indeed, it appears that researchers in Australia did just that last year by developing what they called «3 - D replacement skin» which combines «stem cells with synthetic materials like collagen, elastin and other products.»